tirzepatide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42630863
Attitudes Toward Injectable GLP-1 Drugs for Obesity Treatment: A Qualitative Interview Study With Healthcare Professionals.
Attitudes Toward Injectable GLP-1 Drugs for Obesity Treatment: A Qualitative Interview Study With Healthcare Professionals.
- 저자
- Raluca C Capaian, Phillippa Lally, Saskia C Sanderson
- 저널
- Obesity science & practice
- 공개일
- 2026 Apr
- 연구 유형
- 기타
- DOI
- 10.1002/osp4.70130
문헌 요약
Injectable GLP-1 drugs such as semaglutide (Wegovy) and tirzepatide (Mounjaro, a dual GLP-1 and GIP receptor agonist) can help individuals living with obesity to lose weight. UK guidelines currently recommend semaglutide and other injectable GLP-1 drugs are prescribed in specialist (Tier 3) multidisciplinary weight management services, and other settings.…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.